Get startedLog in
    Picture of Greenlight Biosciences Holdings PBC logo

    GRNA — Greenlight Biosciences Holdings PBC News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    All News

    Brief: Greenlight Biosciences And Epivax Therapeutics Collaborates To Develop Personalized Cancer Vaccines

    Picture of Greenlight Biosciences Holdings PBC logoGreenlight Biosciences Holdings PBC
    09/01/2023 13:21
    Jan 9 (Reuters) - Greenlight Biosciences Holdings PBC
 GRNA.O :
    * GREENLIGHT BIOSCIENCES AND EPIVAX THERAPEUTICS SIGN
EXCLUSIVE
COLLABORATION AGREEMENT TO DEVELOP PERSONALIZED CANCER VACCINES
    * GREENLIGHT BIOSCIENCES HOLDINGS PBC- GREENLIGHT WILL
CONTRIBUTE
PROPRIETARY RNA TECHNOLOGY ALLOWING MRNA DESIGN, FORMULATION,
AND MANUFACTURING
    * GREENLIGHT BIOSCIENCES HOLDINGS PBC-  UNDER AGREEMENT
EPIVAX
THERAPEUTICS TO CONTRIBUTE PROPRIETARY SET OF IMMUNOINFORMATICS
TOOLS

Source text for Eikon:  ID:nGNX4pnQsc 
Further company coverage:  GRNA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Greenlight Biosciences Holdings PBC

    See all news